AB
VKTX icon

Amalgamated Bank’s Viking Therapeutics VKTX Stock Holding History

Amalgamated Bank’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+5,315
New +$172K ﹤0.01% 1584
2026
Q1 		– Sell
-5,584
Closed -$196K – 2778
2025
Q4 		$196K Sell
5,584
-220
-4% -$7.79K ﹤0.01% 1572
2025
Q3 		$153K Buy
5,804
+60
+1% +$1.79K ﹤0.01% 1634
2025
Q2 		$152K Sell
5,744
-1,521
-21% -$40K ﹤0.01% 1620
2025
Q1 		$175K Buy
7,265
+265
+4% +$8.38K ﹤0.01% 1560
2024
Q4 		$282K Hold
7,000
– – ﹤0.01% 1484
2024
Q3 		$443K Sell
7,000
-35
-0.5% -$2.05K ﹤0.01% 1344
2024
Q2 		$373K Buy
7,035
+3,578
+104% +$235K ﹤0.01% 1407
2024
Q1 		$283K Sell
3,457
-10,156
-75% -$452K ﹤0.01% 1501
2023
Q4 		$253K Sell
13,613
-965
-7% -$12.6K ﹤0.01% 1722
2023
Q3 		$161K Hold
14,578
– – ﹤0.01% 1853
2023
Q2 		$236K Buy
+14,578
New +$305K ﹤0.01% 1761
2022
Q2 		– Sell
-8,272
Closed -$25K – 3209
2022
Q1 		$25K Buy
+8,272
New +$29.7K ﹤0.01% 2737
2020
Q2 		– Sell
-10,082
Closed -$47K – 1654
2020
Q1 		$47K Sell
10,082
-380
-4% -$2.34K ﹤0.01% 1577
2019
Q4 		$84K Buy
+10,462
New +$76.3K ﹤0.01% 1751

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Amalgamated Bank's VKTX Position: Q2 2026 in Review

Amalgamated Bank opened a new position in Viking Therapeutics (VKTX) in Q2 2026: 5,315 shares worth $207K. The stake represents ﹤0.01% of the portfolio and ranks #1584 among its holdings. This is a return to the name: Amalgamated Bank previously reported a position in VKTX as recently as Q4 2025.

Amalgamated Bank first reported a position in VKTX in Q4 2019 and has held it in 15 quarters since. The position peaked at $443K in Q3 2024. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Amalgamated Bank held 5,315 shares of Viking Therapeutics worth $207K as of Q2 2026.
  • Viking Therapeutics was a new Amalgamated Bank position in Q2 2026.
  • Viking Therapeutics made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1584 holding.
  • Amalgamated Bank first reported a position in Viking Therapeutics in Q4 2019 and has held it in 15 quarters since.
  • Amalgamated Bank's Viking Therapeutics position peaked at $443K in Q3 2024.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.